Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
5.88T | 6.06T | 4.70T | 4.63T | 5.02T | Gross Profit |
10.70T | 6.06T | 4.70T | 4.63T | 5.02T | EBIT |
0.00 | 3.86T | 1.96T | 962.09B | 749.05B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
1.49T | 1.12T | 1.13T | 777.02B | 528.15B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Assets |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Total Debt |
25.75T | 47.28T | 19.11T | 18.09T | 44.91T | Net Debt |
-84.13T | -66.35T | -91.65T | -84.89T | -33.42T | Total Liabilities |
10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | Stockholders Equity |
19.59T | 17.23T | 17.02T | 16.80T | 15.99T |
Cash Flow | Free Cash Flow | |||
-10.31T | 13.03T | 9.25T | 34.51T | 7.61T | Operating Cash Flow |
-9.84T | 13.43T | 9.64T | 34.90T | 8.06T | Investing Cash Flow |
-1.27T | -10.68T | -2.20T | -10.14T | -3.37T | Financing Cash Flow |
8.31B | -977.14B | -875.97B | -436.07B | -251.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $108.64B | 7.68 | 13.25% | 2.36% | 0.27% | 19.44% | |
80 Outperform | $198.30B | 10.44 | 10.30% | 5.80% | -1.91% | -6.79% | |
78 Outperform | $240.16B | 13.26 | 11.05% | 2.10% | 3.51% | 16.51% | |
74 Outperform | $88.31B | 10.53 | 8.86% | 2.38% | 8.69% | 50.61% | |
65 Neutral | $136.50B | 11.23 | 9.70% | 1.92% | 13.21% | -12.06% | |
64 Neutral | $131.84B | 11.11 | 6.33% | 3.13% | 2.97% | 88.51% | |
64 Neutral | $12.61B | 9.79 | 7.95% | 16985.69% | 12.77% | -3.98% |